PTC Therapeutics Inc
PTCT51.815USD
-0.315-0.60%
交易中 （美東）報價延遲15分鐘
4.11B總市值
6.90本益比TTM
關於 PTC Therapeutics Inc 公司
PTC Therapeutics, Inc. 是一家全球性生物製藥公司。該公司專注於發現、開發和商業化臨牀差異化藥物，爲罕見疾病患者帶來益處。該公司擁有多元化的治療產品組合，包括處於不同開發階段的多種商業產品和候選產品，包括髮現、研究和臨牀階段，專注於開發與神經病學和代謝相關的罕見疾病的多個治療領域的新療法。該公司有兩種產品，Translarna (ataluren) 和 Emflaza (deflazacort)，用於治療杜氏肌營養不良症 (DMD)，這是一種罕見的危及生命的疾病。其 Upstaza 是一種基因療法，用於治療芳香族 L-氨基脫羧酶 (AADC) 缺乏症，這是一種罕見的中樞神經系統 (CNS) 疾病。其 Tegsedi 和 Waylivra 用於治療罕見疾病。其 Evrysdi 是一種脊髓性肌萎縮症 (SMA) 的治療方法。
公司簡介
公司代碼PTCT
公司名稱PTC Therapeutics Inc
上市日期Jun 20, 2013
CEODr. Matthew B. Klein, M.D.
員工數量939
證券類型Ordinary Share
年結日Jun 20
公司地址500 Warren Corporate Center Drive
城市WARREN
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編07059
電話19082227000
網址https://www.ptcbio.com/
公司代碼PTCT
上市日期Jun 20, 2013
CEODr. Matthew B. Klein, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Schmertzler
Mr. Michael Schmertzler
Independent Chairman of the Board
Independent Chairman of the Board
126.60K
+0.53%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.68K
-13.92%
Mr. Mark Elliott Boulding
Mr. Mark Elliott Boulding
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
60.20K
--
Ms. Christine Marie Utter
Ms. Christine Marie Utter
Senior Vice President, Chief Accounting Officer, Head - People Services
Senior Vice President, Chief Accounting Officer, Head - People Services
54.45K
-3.13%
Mr. Eric Pauwels
Mr. Eric Pauwels
Chief Business Officer
Chief Business Officer
19.79K
-16.96%
Mr. Pierre Gravier
Mr. Pierre Gravier
Chief Financial Officer
Chief Financial Officer
18.36K
-12.05%
Mr. David P. Southwell
Mr. David P. Southwell
Independent Director
Independent Director
16.17K
+13.98%
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
16.17K
+2.10%
Ms. Emma Reeve
Ms. Emma Reeve
Independent Director
Independent Director
12.87K
+2.66%
Ms. Stephanie S. Okey
Ms. Stephanie S. Okey
Independent Director
Independent Director
6.53K
+5.37%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Schmertzler
Mr. Michael Schmertzler
Independent Chairman of the Board
Independent Chairman of the Board
126.60K
+0.53%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.68K
-13.92%
Mr. Mark Elliott Boulding
Mr. Mark Elliott Boulding
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
60.20K
--
Ms. Christine Marie Utter
Ms. Christine Marie Utter
Senior Vice President, Chief Accounting Officer, Head - People Services
Senior Vice President, Chief Accounting Officer, Head - People Services
54.45K
-3.13%
Mr. Eric Pauwels
Mr. Eric Pauwels
Chief Business Officer
Chief Business Officer
19.79K
-16.96%
Mr. Pierre Gravier
Mr. Pierre Gravier
Chief Financial Officer
Chief Financial Officer
18.36K
-12.05%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
413.04M
51.20%
Non-US
393.74M
48.80%
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.84%
RTW Investments L.P.
9.44%
BlackRock Institutional Trust Company, N.A.
7.50%
Armistice Capital LLC
6.86%
Wellington Management Company, LLP
6.84%
Other
58.52%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.84%
RTW Investments L.P.
9.44%
BlackRock Institutional Trust Company, N.A.
7.50%
Armistice Capital LLC
6.86%
Wellington Management Company, LLP
6.84%
Other
58.52%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
40.10%
Investment Advisor
34.56%
Hedge Fund
20.09%
Research Firm
5.93%
Corporation
1.75%
Venture Capital
0.78%
Pension Fund
0.74%
Individual Investor
0.71%
Bank and Trust
0.31%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
542
83.25M
105.04%
-7.03M
2025Q1
551
82.28M
103.88%
-8.58M
2024Q4
513
80.63M
102.26%
-7.88M
2024Q3
503
82.04M
106.59%
-9.34M
2024Q2
498
82.97M
107.86%
-13.36M
2024Q1
493
89.17M
116.42%
-6.48M
2023Q4
485
88.17M
116.52%
-2.91M
2023Q3
477
85.04M
112.75%
-2.96M
2023Q2
478
84.63M
112.42%
-161.84K
2023Q1
486
82.00M
110.89%
-2.44M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
8.59M
10.84%
-571.45K
-6.24%
Mar 31, 2025
RTW Investments L.P.
7.48M
9.44%
+90.00K
+1.22%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.95M
7.5%
-111.10K
-1.83%
Mar 31, 2025
Armistice Capital LLC
5.43M
6.86%
-943.16K
-14.79%
Mar 31, 2025
Wellington Management Company, LLP
5.42M
6.84%
+632.05K
+13.20%
Mar 31, 2025
Janus Henderson Investors
2.92M
3.68%
+590.81K
+25.40%
Mar 31, 2025
TD Securities, Inc.
2.61M
3.3%
-673.53K
-20.49%
Mar 31, 2025
State Street Global Advisors (US)
2.45M
3.1%
-253.10K
-9.35%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.87M
2.36%
+76.87K
+4.28%
Mar 31, 2025
Driehaus Capital Management, LLC
1.51M
1.91%
+471.59K
+45.30%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
4.12%
Invesco Biotechnology & Genome ETF
2.71%
ALPS Medical Breakthroughs ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.85%
Harbor Human Capital Factor US Small Cap ETF
1.71%
Tema Neuroscience and Mental Health ETF
1.56%
Invesco Dorsey Wright Healthcare Momentum ETF
1.38%
Global X Guru Index ETF
1.29%
SPDR S&P Biotech ETF
1.21%
VictoryShares Small Cap Free Cash Flow ETF
0.88%
查看更多
iShares Neuroscience and Healthcare ETF
佔比4.12%
Invesco Biotechnology & Genome ETF
佔比2.71%
ALPS Medical Breakthroughs ETF
佔比2.62%
Virtus LifeSci Biotech Products ETF
佔比1.85%
Harbor Human Capital Factor US Small Cap ETF
佔比1.71%
Tema Neuroscience and Mental Health ETF
佔比1.56%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比1.38%
Global X Guru Index ETF
佔比1.29%
SPDR S&P Biotech ETF
佔比1.21%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.88%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
